Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice – results from the ElderTac study

BACKGROUND: In this prospective non-interventional study, the effectiveness and tolerability of erlotinib in elderly patients with non-small-cell lung cancer (NSCLC) after ≥1 platinum-based chemotherapy were assessed. METHODS: A total of 385 patients ≥65 years of age with advanced NSCLC receiving er...

Descripción completa

Detalles Bibliográficos
Autores principales: Brueckl, Wolfgang M., Achenbach, H. Jost, Ficker, Joachim H., Schuette, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870245/
https://www.ncbi.nlm.nih.gov/pubmed/29587656
http://dx.doi.org/10.1186/s12885-018-4208-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870245/
https://www.ncbi.nlm.nih.gov/pubmed/29587656
http://dx.doi.org/10.1186/s12885-018-4208-x

Ejemplares similares